Stock RSLS RESHAPE LIFESCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Market Closed - Nasdaq
Other stock markets
 02:00:01 04/05/2024 am IST 		5-day change 1st Jan Change
0.1693 USD -3.42% Intraday chart for ReShape Lifesciences Inc. -0.29% -32.20%
12/04 North American Morning Briefing : Big Banks Kick -2- DJ
01/04 Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Big Banks Kick -2-
DJ
Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
AQ
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System
MT
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
AQ
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Intragastric Balloon System
CI
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
AQ
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
AQ
Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex
CI
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
AQ
ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex
AQ
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
AQ
Top Midday Gainers
MT
North American Morning Briefing : Traders Await FOMC, Powell
DJ
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. News ReShape Lifesciences Inc.